| | Submission of a manuscript implies that it contains original work and has not been published or submitted for publication elsewhere. It
also implies the transfer of the copyright from the author to the publisher. Authors should include permission to reproduce any previously
published material. Any potential conflict of interest should be disclosed in the cover letter. Authors are also requested to include
contact information (name, address, telephone, fax, and e-mail) for three potential peer reviewers, to be used at the Editor's discretion.
The review process requires 2 to 5 months.
Manuscript Submission
The Journal of Affective Disorders now proceeds
totally online via an electronic submission system. Mail submissions will no longer be accepted. By accessing the online submission system
through the Author Gateway,  http://ees.elsevier.com/jad/, you will be guided stepwise through the creation and uploading
of the various files. When submitting a manuscript online, authors need to provide an electronic version of their manuscript and any
accompanying figures and tables.
The author should select from a list of scientific classifications, which will be used to help
the editors select reviewers with appropriate expertise, and an article type for their manuscript. Once the uploading is done, the system
automatically generates an electronic (PDF) proof, which is then used for reviewing. All correspondence, including the Editor's decision
and request for revisions, will be processed through the system and will reach the corresponding author by e-mail.
Once a manuscript
has successfully been submitted via the online submission system authors may track the status of their manuscript using the online submission
system (details will be provided by e-mail). If your manuscript is accepted by the journal, subsequent tracking facilities are available
on Elsevier's Author Gateway, using the unique reference number provided by Elsevier and corresponding author name (details will be provided
by e-mail).
Authors may send queries concerning the submission process or journal procedures to the appropriate Editorial Office:
For Europe, Asia (except Japan), and Australasia: C. Katona, Wingham Barton Manor, Westmarsh, Canterbury CT3 2LW, UK; E-mail: journalaffdis@googlemail.com.
For the American Hemisphere, Africa, and Japan: H.S. Akiskal, University of California
at San Diego, V.A. Psychiatry Service (116A), 3350 La Jolla Village Dr., San Diego, CA 92161, USA; E-mail: hakiskal@ucsd.edu.
For further details on how to submit online, please refer to the online EES Tutorial for authors or contact Elsevier's Author Support
Team at authorsupport@elsevier.com.
Types of Papers
The Journal primarily publishes
full-length
Research Reports describing original work (4000-5000 words, excluding references and up to 6 tables/figures)
Brief Reports
(1500-2000 words, excluding references and a msximum of 2 tables/figures)
evidence-based Review Articles (up to 8000 words,
excluding references and up to 10 tables/figures). Reviews should be systematic and give details as to search strategy used.
Rapid
Communications (1500-2000 words, excluding references and a maximum of 2 tables/figures).
Preliminary Communications (up
to 3000 words, excluding references and maximum 3 tables/figures).
Books for review should be sent to the appropriate editorial
office (see above).
At the discretion of the accepting Editor-in-Chief, and/or based on reviewer feedback, authors may be allowed
fewer or more than these guidelines.
Preparation of Manuscripts
Articles should be in English. The title page should
appear as a separate sheet bearing title (without article type), author names and affiliations, and a footnote with the corresponding
author's full contact information, including address, telephone and fax numbers, and e-mail address (failure to include an e-mail address
can delay processing of the manuscript).
Papers should be divided into sections headed by a caption (e.g., Introduction, Methods,
Results, Discussion). A structured abstract of no more than 250 words should appear on a separate page with the following headings and
order: Background, Methods, Results, Limitations, Conclusions (which should contain a statement about the clinical relevance of the research).
A list of three to six key words should appear under the abstract.
Author Disclosure - NEW!!
Role of Funding
Source. Authors are kindly requested to briefly describe the role of the study sponsor(s), if any, in study design; in the collection,
analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. If the funding
source(s) had no such involvement, authors should so state.
eg, Funding for this study was provided by NIMH Grant XXXXXXX; the
NIMH had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in
the decision to submit the paper for publication.
The second aspect of the Journal's new policy concerns the Conflict of
Interest. ALL authors are requested to disclose any actual or potential conflict of interest including any financial, personal or
other relationships with other people or organizations within three (3) years of beginning the work submitted that could inappropriately
influence, or be perceived to influence, their work.
Examples of potential conflicts of interest which should be disclosed include
employment, consultancies, stock ownership (except for personal investment purposes equal to the lesser of one percent (1%) or USD 5000),
honoraria, paid expert testimony, patent applications, registrations, and grants. If there are no conflicts of interest, authors should
state that there are none.
eg, Author Y owns shares in pharma company A. Author X and Z have consulted for pharma company B.
All other authors declare that they have no conflicts of interest.
Finally, before the references, the Journal will publish Acknowledgements, in a separate section, and not as a footnote on the title page.
eg, We thank Mr A, who kindly provided
the data necessary for our analysis, and Miss B, who assisted with the preparation and proof-reading of the manuscript.
The
submitting author is also required to make a brief statement concerning each named author's contributions to the paper under the headingng Contributors. This statement is for editorial purposes only and will not be published with the article.
eg, Author X designed
the study and wrote the protocol. Author Y managed the literature searches and analyses. Authors X and Z undertook the statistical analysis,
and author W wrote the first draft of the manuscript. All authors contributed to and have approved the final manuscript.
NB.
During the online submission process the author will be prompted to upload these four mandatory author disclosures as separate items.
They will be automatically incorporated in the PDF builder of the online submission system. Please do not include in the main manuscripts.
References
References should be cited in text by authors' names and year of publication (Harvard system). When referring
to a work of more than two authors, the name of the first author should be used with 'et al.'(examples: Brown, 1992; Brown and Bifulco,
1992; Brown et al., 1993, a, b).
All references cited in text should be listed at the end of the paper (double spaced) arranged in
alphabetical order of first author. More than one paper from the same author in the same year should be identified by the letter (a,
b, c, etc.) after the year of publication.
The reference list should contain names and initials of all authors, year, title of paper
referred to, abbreviated title of periodical (per Index Medicus), volume, and inclusive page numbers. This Journal should be cited in
the list of references as J. Affect. Disord. Periodicals, books, and multi-author titles should accord with the following examples:
Bauer, M.S., Shea, N., McBride, L., Gavin, C., 1997. Predictors of service utilization in veterans with bipolar disorder: a prospective
study. J. Affect. Disord. 44, 159-168.
Gelenberg, A.J., Bassuk, E.L., Schoonover, S.C., 1991. The Practitioner's Guide to Psychoactive
Drugs. Plenum Medical Book Company, New York, NY.
Willner, P., 1995. Dopaminergie mechanisms in depression and mania. In: Bloom,
F.E. and Kupfer, D.J. (Eds.), Psychopharmacology: The Fourth Generation of Progress. Raven Press, NY, pp. 921-931.
Figures and
Photographs
Figures and Photographs of good quality should be submitted online as a separate file. Please use a lettering that
remains clearly readable even after reduction to about 66%. For every figure or photograph, a legend should be provided. All authors
wishing to use illustrations already published must first obtain the permission of the author and publisher and/or copyright holders
and give precise reference to the original work. This permission must include the right to publish in electronic media.
Tables
Tables should be numbered consecutively with Arabic numerals and must be cited in the text in sequence. Each table, with an appropriate
brief legend, comprehensible without reference to the text, should be typed on a separate page and uploaded online. Tables should be
kept as simple as possible and wherever possible a graphical representation used instead. Table titles should be complete but brief.
Information other than that defining the data should be presented as footnotes.
Please refer to the generic Elsevier artwork instructions:
http://authors.elsevier.com/artwork/jad.
Colour reproduction
The Journal of Affective Disorders
is now also included in a new initiative from Elsevier: 'Colourful e-Products'. Through this initiative, figures that appear in black & white in print can
appear in colour, online, in ScienceDirect at http://www.sciencedirect.com.
There is no extra
charge for authors who participate.
For colour reproduction in print, you will receive information regarding the costs from Elsevier
after receipt of your accepted article. Please indicate your preference for colour in print or on the Web only. Because of technical
complications which can arise by converting colour figures to "grey scale" (for the printed version should you not opt for colour in
print) please submit in addition usable black and white versions of all the colour illustrations. For further information on the preparation
of electronic artwork, please see http://authors.elsevier.com/artwork/jad.
Copyright Transfer
Upon acceptance
of an article, you will be asked to transfer copyright (for more information on copyright see http://authors.elsevier.com/journal/jad.
This transfer will ensure the widest possible dissemination of information. If excerpts from other copyrighted works are included in
the submission, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier
has preprinted forms for use by authors in these cases: contact Elsevier's Rights Department, Philadelphia, PA, USA: phone (+1) 215 238
7869, fax (+1) 215 238 2239, e-mail healthpermissions@elsevier.com.
Requests for materials from other Elsevier publications
may also be completed on-line via the Elsevier homepage http://www.elsevier.com/locate/permissions
Proofs
One set of proofs in PDF format will be sent by email to the corresponding Author, to be checked for typesetting/editing. No changes
in, or additions to, the accepted (and subsequently edited) manuscript will be allowed at this stage. Proofreading is solely your responsibility.
A form with queries from the copyeditor may accompany your proofs. Please answer all queries and make any corrections or additions required.
The Publisher reserves the right to proceed with publication if corrections are not communicated. Return corrections within 2 days of
receipt of the proofs. Should there be no corrections, please confirm this.
Elsevier will do everything possible to get your article
corrected and published as quickly and accurately as possible. In order to do this we need your help. When you receive the (PDF) proof
of your article for correction, it is important to ensure that all of your corrections are sent back to us in one communication. Subsequent
corrections will not be possible, so please ensure your first sending is complete. Note that this does not mean you have any less time
to make your corrections, just that only one set of corrections will be accepted.
Reprints
Twenty-five reprints are provided
free of charge. Additional copies may be ordered via the reprint order form sent with the proofs. There are no page charges.
Author
enquiries
For enquiries relating to the submission of articles please visit Elsevier's Author Gateway at http://authors.elsevier.com/journal/jad
. The Author Gateway also provides the facility to track accepted articles and set up e-mail alerts to inform you of when an article's
status has changed, as well as detailed artwork guidelines, copyright information, frequently asked questions and more. Contact details
for questions arising after acceptance of an article, especially those relating to proofs, are provided after registration of an article
for publication |
| |
|
